Kendall Capital Management

Position in INCY — Incyte Corp

CIK 1731372 ROCKVILLE, MD

Position in INCY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,448,740

+$620,014 QoQ

Shares Held

12,780

+45.1% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#374

of 854 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kendall Capital Management holds $6,297,958 across 5 Biotechnology names. INCY ranks #2 (23.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	9,719	$2,341,987
2	INCY	Incyte Corp This page	12,780	$1,448,740
3	REGN	Regeneron Pharmaceuticals, Inc.	2,196	$1,369,293
4	INVA	Innoviva, Inc.	38,580	$876,151
5	HRMY	Harmony Biosciences Holdings, Inc.	7,190	$261,787

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,448,740	12,780	+45.1%	Shares	Sole	2026-08-12
2026-03-31	$828,726	8,805	+9.7%	Shares	Sole	2026-04-24
2025-12-31	$793,123	8,030	+35.0%	Shares	Sole	2026-01-16
2025-09-30	$504,619	5,950	—	Shares	Sole	2025-11-13
No filing history on record for this holder in this stock.